Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ImmunoSphere is an immunomodulatory product primarily composed of **Transfer Factors**, which are low-molecular-weight dialyzable peptides and proteins derived from bovine colostrum or avian egg yolks. It functions as a biological response modifier by transferring cell-mediated immunity and "educating" the recipient's immune system to recognize and respond to specific antigens. ImmunoSphere is extensively utilized in the **aquaculture** industry (particularly for shrimp and fish) and **poultry** to enhance innate immunity and improve survival rates against viral and bacterial pathogens, such as White Spot Syndrome Virus (WSSV). In humans, it is marketed as a **nutraceutical** or dietary supplement for immune support and as an adjunct in treating chronic infections and certain cancers, although it is not typically regulated as a primary pharmaceutical drug in most jurisdictions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ImmunoSphere.